Soft tissue sarcomas: From a morphological to a molecular biological approach.

about

Soft tissue sarcomas: From a morphological to a molecular biological approach.

Item

http://www.wikidata.org/entity/Q51817033

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@en

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@nl

type

Item

label

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@en

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@nl

prefLabel

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@en

Soft tissue sarcomas: From a morphological to a molecular biological approach.

@nl

P1476

Soft tissue sarcomas: From a morphological to a molecular biological approach

@en

P2093

Akira Maekawa

http://www.w3.org/2001/XMLSchema#string

Hidetaka Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hirofumi Bekki

http://www.w3.org/2001/XMLSchema#string

Kenichi Kohashi

http://www.w3.org/2001/XMLSchema#string

Kunio Iura

http://www.w3.org/2001/XMLSchema#string

Yoshinao Oda

http://www.w3.org/2001/XMLSchema#string

Yuichi Yamada

http://www.w3.org/2001/XMLSchema#string

P2860

Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Modulation of Akt kinase activity by binding to Hsp90

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

Exploiting the PI3K/AKT pathway for cancer drug discovery

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.

Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.

P304

435-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PIN.12565

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeaki Ishii

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28759137

http://www.w3.org/2001/XMLSchema#string